SARS-CoV-2 S antibody 100ul
| Target Name | S | ||||||
| Alternative Names | S, S1, S1-RBD, Spike glycoprotein | ||||||
| Species Reactivity | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ||||||
| Immunogen | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (16-685aa) | ||||||
| Immunogen Species | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ||||||
| Conjugate | Non-conjugated | ||||||
| Clonality | Monoclonal | ||||||
| Isotype | Mouse scFv fusion with human IgG1 Fc | ||||||
| Clone No | H6 | ||||||
| Purification Method | Affinity-chromotography | ||||||
| Concentration | It differs from different batches. Please contact us to confirm it | ||||||
| Buffer |
| ||||||
| Form | Liquid | ||||||
| Tested Applications | ELISA, GICA | ||||||
| Recommended Dilution |
| ||||||
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. | ||||||
| Description | Recombinant anti-SARS-CoV-2 spike Mouse ScFv is expressed from 293 cells (HEK293) with a human IgG1 Fc tag on C-terminal. |
